Skip to main content
RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
0.840
-0.030 (-3.46%)
At close: Apr 28, 2026, 4:00 PM EDT
0.845
+0.005 (0.60%)
After-hours: Apr 28, 2026, 4:04 PM EDT

RenovoRx Revenue

In the year 2025, RenovoRx had annual revenue of $1.12M with 2,511.63% growth. RenovoRx had revenue of $238.00K in the quarter ending December 31, 2025, with 453.49% growth.

Revenue (ttm)
$1.12M
Revenue Growth
+2,511.63%
P/S Ratio
33.70
Revenue / Employee
$66,059
Employees
17
Market Cap
37.84M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20251.12M1.08M2,511.63%
Dec 31, 202443.00K--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Atara Biotherapeutics 120.77M
Veru Inc. 16.89M
Palatin Technologies 8.96M
Plus Therapeutics 5.21M
Aligos Therapeutics 2.19M
Werewolf Therapeutics 1.14M
Actinium Pharmaceuticals 90.00K
INmune Bio 50.00K
Revenue Rankings

RNXT News

More News